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Abstract: This study investigated the clinical use of a medetomidine/propofol TIVA technique in horses.
Twenty-seven equidae of mixed breed, age [mean ± SD (range)] 2.9 ± 2.74 (0.11–11) years, weight (n
= 15) 237 ± 130.22 (64–470) kg were anaesthetized for the following procedures: intra-abdominal (3);
castration (15); joint flush (4); screw removal (1); desmotomy (3) and dermatoma removal (1). Horses
were sedated with 7 µg kg−1 medetomidine IV and 10 minutes later anaesthesia was induced with 2 mg
kg−1 propofol IV. Incremental doses of medetomidine were given prior to induction if the horse lifted
its head when approached. Following induction, trachea were intubated and oxygen administered at
FIO2 > 90%. Anaesthesia was maintained with 3.5 µg kg−1 h−1 medetomidine IV and propofol infused
to effect (initial dose 0.1 mg kg−1min−1) 1. Heart rate, respiratory rate, propofol dose and arterial
blood pressure were recorded every five minutes and arterial blood gases every 15 minutes. Quality of
sedation, anaesthetic induction and recovery were evaluated by the first author according to previously
described scores ( Bettschart-Wolfensberger et al. 1998). Data were analysed in a preliminary manner by
descriptive statistical methods. Twelve horses required additional medetomidine for adequate sedation
prior to induction (2 µg kg, n = 11; 6 µg kg, n = 1). Induction to anaesthesia was variable; excellent in 3,
good in 18, fair in 4 and poor (unsatisfactory) in 2 horses. In an additional horse, induction to anaesthesia
was very poor and transfer from the induction area to theatre was not possible, due to limb movement,
even after several IV doses of propofol (total dose 2 mg kg−1) and thiopentone (total dose 2.5 mg kg−1).
The use of propofol as an induction agent was stopped after this incident. During anaesthesia, range
of mean values (absolute range) were, for respiratory rate 4.8–12.4 (4–32) min−1, heart rate 36.3–46.8
(15–58) min−1, mean arterial blood pressure 95.6–111 (84–128) mm Hg, propofol infusion 0.063–0.18
mg kg−1min−1, PaO2 23.2–31.8 (11.7–59.7) kPa, PaCO2 6.1–7 (5.2–8.5) kPa. Anaesthetic quality
was excellent and spontaneous movement occurred in six horses but was slow and easily controlled with
increments of propofol. Anaesthetic duration was 57.9 ± 38.16 (15–175) minutes. Recovery was completed
unaided within 24.3 ± 10.66 (10–44.8) minutes. It was uneventful in all horses. Medetomidine/propofol
TIVA at the dose rates studied produced good quality anaesthesia with cardiopulmonary depression
within ranges commonly recorded during inhalation anaesthesia in horses. However the quality of the
anaesthetic induction was variable, and appeared inferior to that achieved with induction techniques
which included ketamine.
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Assessment of a medetomidine/propofol total
intravenous anaesthesia (TIVA) for clinical anaesthesia
in equidae
Regula Bettschart-Wolfensberger, Sarah Freeman, R. W. Bettschart, A. Fürst and Kathleen W. Clarke
Veterinär-Chirurgische Klinik der Universität Zürich, Schweiz
Summary
This study investigated the clinical use of a medetomidine/propofol TIVA technique in horses. Twenty seven equidae of mixed breed, age
[mean (SD (range)] 2.9 ±  2.74 (0.11–11) years, weight 237 ±  130.22 (64–470) kg (in 12 horses, anaesthetised in the field weight was not
scaled but judged by the first authour) were anaesthetised. The following surgeries were performed: intraabdominal (3), castration (15), joint
flush (4), screw removal (1), desmotomy (3), dermatoma removal (1).
In the field 6 wild horses were premedicated with 0.03 mg/kg acepromazine IM. All the horses were sedated with 7mcg/kg medetomidine
IV, anaesthesia was induced 10 minutes later with 2 mg/kg propofol IV. If the patient lifted its head when beeing approached for propofol
administration, sedation was deepened with incremental boli of medetomidine. After anaesthesia induction trachea was intubated and
oxygen administered at FIO2 >90% in 15 horses. Anaesthesia was maintained with 3.5mcg/kg/h medetomidine IV and propofol infused
to effect (initial dose 0.1mg/kg/min). Heart rate, respiratory rate, propofol dose and arterial blood pressure were recorded every five
minutes and arterial blood gases every 15 minutes. Quality of sedation, anaesthetic induction and recovery were graded. Arterial
bloodpressures and arterial blood gases were analysed in a preliminary manner by descriptive statistical methods. Heart rates and
respiratory rates were analysed using ANOVA for repeated measures. To detect differences to preanaesthetic values Dunnett‘s post test
was performed. Eleven horses required additional 2 mcg/kg and one horse 6 mcg/kg medetomidine for adequate sedation prior to
induction. Induction of anaesthesia was variable: excellent in 3, good in 18, fair in 4 and poor (unsatisfactory) in 2 horses. In a 28th horse
anaesthesia induction was very poor and transfer from induction area to theatre was not possible even after application of several boluses
of propofol (total dose 2 mg/kg) and thiopentone (total dose 2.5 mg/kg) as whenever lifted paddeling of the limbs occurred. The use of
propofol as an induction agent was stopped after this incidence. After sedation three horses showed second degree AV blocks two of
which were treated with atropine. Compared to presedation values respiratory rate as well as heart rate were significantly reduced
throughout anaesthesia. During anaesthesia, range of mean values (absolute range) were, for respiratory rate 12.4–17.7 (4–32) breaths/
min, heart rate 36.3–46.8 (15–58) bpm, mean arterial blood pressure 95.6–111 (84–128) mmHg, propofol infusion 0.063–0.18mg/
kg/min, paO2 23.2–31.8 (11.7–59.7) kPa, paCO2 6.1–7 (5.2–8.5) kPa. Anaesthetic quality was excellent: spontaneous movement
occurred in 6 horses, but was slow and easily controlled with increments of propofol (0.05–0.1 mg/kg). Anaesthetic duration was 57.9
(38.16 (15–175) min. Recovery was completed unaided within 24.3 (10.66 (10–44.8) min. It was uneventful in all horses. Medetomidine-
propofol TIVA at dose rates administered in the current study produced good quality anaesthesia with cardiopulmonary depression within
ranges commonly recorded during inhalation anaesthesia in horses. However anaesthetic induction was variable, and appeared to be
inferior to that achieved with induction regimes including ketamine.
Keywords: anaesthesia, horse, medetomidine, propofol, total intravenous anaesthesia
Anwendung von Medetomidin-Propofol Total Intravenöser Anästhesie (TIVA) in der Pferdepraxis
In der vorliegenden Studie wurde bei 16 Pferden in einer Klinik und bei 12 Pferden unter Feldbedingungen die Anwendung von Medetomidin
und Propofol zur Allgemeinanästhesie getestet. Sie waren 0,11–11 Jahre alt (2,9 ±  2,74; Mittelwert ±  Standardabweichung), wogen 64–470
(237 ±  130,22) kg und waren von unterschiedlicher Rasse. Folgende Operationen wurden durchgeführt: Entfernung von Knochenimplantaten
(1), Desmotomie (3), Gelenkspülung (4), Kastration (15), Dermatom Entfernung (1), Kastration intraabdominaler Hoden (3).
Unter Feldbedingungen wurden die Pferde mit 0,03 mg/kg Acepromazin i.m. prämediziert. Alle Pferde erhielten 7 µg/kg Medetomidin i.v. zur
Sedation. Nach 10 Minuten wurde die Anästhesie mit 2 mg/kg Propofol i.v. eingeleitet. Die Pferde atmeten spontan, in der Klinik wurden sie
intubiert und atmeten > 90% O2. Die Anästhesie wurde aufrecht erhalten durch eine konstante Infusion von Medetomidin (3,5 µg/kg/h) und
Propofol infundiert nach Wirkung (initiale Dosis 0,1 mg/kg/min). Arterielle Blutdruck- und arterielle Blutgaswerte wurden durch deskriptive
Statistik ausgewertet. Herz- und Atemfrequenzen wurden mittels Varianzanalyse für wiederholte Messungen untersucht und Unterschiede zu
präanästhetischen Werten mittels Dunnet’s T-test ermittelt.
Die Qualität der Einleitung war sehr gut bei 3, gut bei 18, zufriedenstellend bei 4 und nicht zufriedenstellend bei 2 Pferden. Beim 28sten
Pferd war die Einleitungsphase so unruhig, dass es trotz Propofol- (2 mg/kg) sowie Thiopenthalapplikation (2,5 mg/kg) nicht aufhörte zu
bewegen und deshalb nicht in den Operationsraum transportiert werden konnte. Es kam während der Anästhesie zu einem signifikanten
Abfall der Atem- sowie der Herzfrequenz. Die Bereiche der Mittelwerte (Minima-Maxima) der überwachten Parameter während der
Anästhesie betrugen: Atemfrequenz: 12,4–17,7 (4–32) Atemzüge/min, Herzfrequenz: 36,3–46,8 (15–58) Schläge/min, mittlerer arterieller
Blutdruck 95,6–111 (84–128) mmHg, paO2: 32,2–31,8 (11,7–59,7) kPa, PaCO2: 6,1–7 (5,2–8,5) kPa. Die Propofolinfusionsrate betrug
0,063–0,18 mg/kg/min. Die Anästhesiequalität war exzellent und alle Eingriffe konnten erfolgreich durchgeführt werden. Nach einer
Anästhesiedauer von 15–175 Minuten (im Mittel 57,9) standen die Pferde innerhalb von 10–44,8 Minuten (im Mittel 24,3) ruhig auf. Die
Qualität der Einleitung war sehr unterschiedlich und teilweise von unakzeptabler Qualität. Deshalb empfehlen die Autoren zur
Anästhesieeinleitung von Pferden Ketamin dem Propofol vorzuziehen. Hingegen bewirkte Propofol in Kombination mit Medetomidin zur
Aufrechterhaltung einer Allgemeinanästhesie geringe Nebenwirkungen auf Herz, Kreislauf und Atmung. Außerdem verliefen die
Aufwachphasen ruhig und waren von kurzer Dauer.
Schlüsselwörter: Anästhesie, Pferd, Medetomidin, Propofol, total intravenöse Anästhesie
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Introduction
Anaesthesia related fatality rate is higher in horses than in any
other domestic species (Johnston et al., 1995). One of the few
facts known about this phenomenon is that the length of
anaesthesia significantly influences the outcome (Johnston et
al., 1995). An increase in risk with anaesthesia duration was
noted, probably related to the cardiopulmonary depressant ef-
fects of halothane and the fact that horses are more prone to
develop problems due to cardiopulmonary depression than
small animals or humans. Total intravenous anaesthesia (TIVA)
is less cardiopulmonary depressant than clinically used inhalatio-
nal anaesthetic regimes (Luna et al., 1996). Thus it would seem
to be wise to anaesthetise horses for long anaesthesias using
TIVA combinations. However, most TIVA in horses include ket-
amine, but with infusions of 2 hours or longer, ketamine’s ma-
jor metabolite norketamine accumulates (Taylor and Luna, 1995;
Nolan et al., 1996). Due to its hallucinatory properties (Chang
and Glazko, 1974), norketamine may lead to signs of appa-
rent ketamine overdose during the horses recovery (Wolfens-
berger, 1993; Taylor and Luna, 1995; Bettschart-Wolfensberger
et al., 1996; Nolan et al., 1996). Therefore TIVA involving ket-
amine is not ideal for longer anaesthesias.
To create a TIVA regime suitable for long anaesthesias in hor-
ses, a combination of medetomidine and propofol, has been
elaborated (Bettschart-Wolfensberger et al., 2001a). Com-
pared to other work that explored the use of propofol in this
species in combination with other sedatives (Nolan and Hall,
1985; Taylor, 1989a; Hartsfield et al., 1994; Matthews et al.,
1994; 1997; Mama et al., 1998; Taylor et al., 1997), medeto-
midine induced major dose reductions of propofol. The resul-
ting cardiovascular depression was remarkably low (Bettschart-
Wolfensberger et al., 2001b) and was comparable to other
TIVA regimes including ketamine (Greene et al., 1986; Young
et al., 1993; Bettschart-Wolfensberger et al., 1996, Luna et al.,
1996), but less than with clinically used inhalational anaesthe-
tic regimes (Luna et al., 1996).
Medetomidine-propofol TIVA has been tested in experimental
animals in anaesthesias as long as 4 hours (Bettschart-Wolfens-
berger et al., 2001a+b). Anaesthesia was easy to maintain
and control. Even after the long duration of 4 hours of anaesthe-
sia, recoveries were quick and of good quality. Under clinical
conditions other factors than length of anaesthesia influence
the outcome as for example type of surgery (Young and Taylor,
1993), nature (Whitehair et al., 1993), clinical condition and
body weight of the horse (Johnston et al., 1995a). Thus a defi-
nitive testing of any new drug combination is only possible un-
der clinical circumstances.
The present study wanted to test clinically medetomidine-pro-
pofol anaesthesia during all types of surgeries in horses of dif-
ferent breed, weight, character and age.
Materials and methods
Animals
The previously elaborated TIVA regime with medetomidine and
propofol was tested in a total of 27 equidae. In a 28th horse
anaesthesia was only induced, but then the horse was allowed
to recover without surgery because of occurring problems. 15
of the animals that underwent surgery were surgical patients
and were anaesthetised inside a hospital henceforth termed
„under clinical conditions“. Another 12 animals were anaesthe-
tised under field conditions. These were all stallions that had
been raised in the field and had not been handled at all before
the day of the surgery. Details of the animals and the surgeries
performed are listed in table 1.
Protocol
The patients, that were anaesthetised under clinical conditions,
were starved for 8–12 hours, if circumstances allowed this. A
clinical examination was performed and if any abnormalities
were detected, blood testing was done. Resting heart and re-
spiratory rates were noted. Before the anaesthesia a catheter
(Secalon⎪, Ohmeda, Hatfield, U.K.) was placed in the jugular
vein and 8 horses were treated with penicillin (Peni G, Streuli
AG, Switzerland) and gentamycin (Gentamycin Streuli, 10%®,
Streuli AG, Switzerland) i.v.. No analgesics were administered.
The stallions that were castrated under field conditions were
starved for 8–12 hours. To avoid injuries of people involved, 6
of the stallions were premedicated with 0.03 mg/kg acepro-
mazine (ACP®, C-Vet, Leyland, U.K.) i.m. and left unattended
for 30 minutes. A clinical examination followed then, resting
heart and respiratory rate were noted and a catheter (Seca-
lon⎪, Ohmeda, Hatfield, U.K.) was placed in the jugular vein.
In both groups the animals were sedated by slow i.v. injection
(over 2 minutes) of 7 µg/kg of medetomidine. Then they were
given ten minutes to achieve maximal sedation. If sedation was
considered unsatisfactory (i.e. the animal still reacting with a lift
of the head or some steps backwards when being approached),
Tab. 1: Signalementof 27 equidae anaesthetised with medetomidine-propofol and type of surgery
Signalement und Art des chirurgischen Eingriffs von 27 Equiden anästhesiert mit Medetomidin-Propofol
Anaesthesias under clinical conditions Anaesthesias under field conditions
age, mean ± SD
(range)
3.5 ± 3.29 (0.1–11) years 1.8 ± 0.41 (1–2) years
weight mean ± SD
(range) 240.0 ± 1.07 (64–470) kg
231.6 ± 135.12 (120–450) kg; the weight of these stallions was
not scaled but only judged by an experienced anaesthetist
breed
6 Warm Blood horses, 4 Thoroughbred, 1 donkey,
2 Shetland ponies, 2 ponies 7 Warm Blood horses, 5 ponies
type of surgery
joint flush (3), intraabdominal (3), screw removal
(1), desmotomy (1), wound revision (3), dermato-
ma removal (1), castration (3)
all castrations
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another 2–5 µg/kg of medetomidine were administered and
anaesthesia induction delayed until satisfactory sedation was
present. Just before induction heart and respiratory rate were
noted again.
Anaesthesia was induced by i.v. injection of 2 mg/kg of propo-
fol in all animals.
Under clinical conditions patients were intubated just after
anaesthesia induction, and were allowed to breath >90 % oxy-
gen spontaneously. Anaesthesia was maintained with an infu-
sion of propofol started at an infusion rate of 0.1 mg/kg/min
and adjusted to the patients needs, using a syringe pump
(P 4000, IVAC, Basingstoke, U. K.). Infusion rates of propofol
were noted every 5 minutes. The clinical patients further got a
continuous infusion of medetomidine at a dose rate of 3.5 µg/
kg/h of medetomidine throughout the whole anaesthesia. Rin-
gers lactate at a dose rate of 5 ml/kg/h was infused to clinical
patients as well. 10 minutes after the end of the propofol infu-
sion clinical patients were given 2 µg/kg of medetomidine to
calm recovery.
Under field conditions boli of propofol (0.085–0.105 mg/kg)
were administered by hand injection every minute, according
to the patients need and every five minutes the amount of pro-
pofol given was noted.
Measurements
After anaesthesia induction phases of apnoea were recorded
and the position of the horses body during surgery was noted.
Heart rate and respiratory rate were recorded every 5 minutes
in all animals. In the field, heart rate was counted by palpating
the pulse and respiratory rate by counting chest wall move-
ments. Under clinical circumstance the patients were connec-
ted to an ECG (Kontron, Watford, U. K.) and intra-arterial blood
pressure was measured continuously via a catheter in either the
facial or the transverse facial artery. Arterial blood gas analysis
was performed every 15 minutes.
Arterial blood pressures and arterial blood gases were ana-
lysed in a preliminary manner by descriptive statistical methods.
Heart rates and respiratory rates were analysed using ANOVA
for repeated measures. To detect differences to preanaesthetic
values Dunnett‘s post test was performed.
If horses moved or any other side effects occurred, it was
noted.
Surgeons were asked to judge relaxation and surgery con-
ditions at the end of the procedure as good, adequate or unsa-
tisfactory.
Induction and recovery
During induction one person stayed with the animal holding its
head, to give a little support. We recorded during induction:
Time from the end of propofol injection to recumbency and any
striking events concerning induction. Quality of induction was
graded based on a scale of 1 (worst) to 5 (best) represented in
table 2.
For recovery the animals were left unattended in a smoothly
padded recovery box (clinical cases) or in the field. Clinical
patients were given 2 mg/kg of medetomidine 10 minutes after
the end of the propofol infusion. When they started swallowing
the endotracheal tube was removed, and the time noted. Qua-
lity of recovery was scored based on a scale of 1 (worst) to 5
(best) as described in table 2. Additionally during recovery the
time of first movement, the time of first head lift, duration of
sternal recumbency, time to gain standing position and the num-
ber of attempts to stand up were noted.
Results
Anaesthesia induction
A foal of 6 weeks, that was suffering from polyartheritis and a
temperature of 39.6° C was given only 3 µg/kg of medetomi-
dine, which induced sedation that seemed adequate for
anaesthesia induction.
In all 12 of the stallions in the field an additional bolus of 2 µg/
kg and in one a bolus of 6 µg/kg of medetomidine was neces-
sary, to achieve sedation that, subjectively assessed by the
anaesthetist, seemed to be adequate for anaesthesia induc-
tion. Overall induction was excellent (5) in 3, good (4) in 18,
fair (3) in 4, poor (2) in 2 and very poor (1) in one animal. One
horse that showed a poor induction was a 2 year old stallion
weighing 170 kg that had been very difficult to handle. It showed
paddling of the limbs and spasms of the whole body up to one
minute. The second one was a 6 year old cryptorchid thorough-
bred stallion weighing 470 kg that was anaesthetised under
clinical conditions. Both animals had seemed adequately seda-
ted before anaesthesia induction.
The horse that showed a very poor induction was an 11 year
old Warm Blood of 330 kg, that required the removal of screws
from the radius. It had shown deep sedation, but its heart rate
had dropped from 48 before medetomidine administration to
Fig. 2: Induction and recovery scores.
Skala zur Beurteilung der Qualität von Anästhesieeinleitung und Auf-
wachphase
score description
1 very poor , unpredictable fall of thehorse, the horse being injured
2 poor , attaining recumbencyunpredictably, but no injuries
3
fair, horse slowly attains sternal or
lateral recumbency, marked paddling
of limbs or shaking  of head
4
good , horse slowly attains
recumbency, only slight paddling of
limbs or shaking of the head
induction
5
excellent , recumbency achieved
slowly and smoothly, no paddling or
head shaking
1 very poor , bad recovery with highrisc of injury
2 poor,  more than one attempt to
stand, horse excited
3 good, but more than one attempt tostand, horse stays calm
4
good , 1 attempt to stand, some
ataxia
recovery
5 excellent , 1 attempt to stand,minimal or no ataxia
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15 beats/min. Thus a bolus of 1 mg atropine was given i.v. 5
minutes later its heart rate was regular with a frequency of 32
beats/min, sedation seemed to be adequate and anaesthesia
was induced. The horse fell over backwards 45 seconds after
the propofol and started paddling extensively and trying to lift
its head. By sitting on its head it was maintained on the floor
and the immediate administration of propofol to effect was star-
ted. During the next 2–3 minutes the horse was administered
66 ml of propofol (1%), the equivalent of its induction dose. As
paddling became more severe, thiopentone was administered,
until after a dose of 1 gr the horse became calm. It was intuba-
ted, supplementation of oxygen (15 l/min) started immediately
and then it was connected to a hoist. After the thiopentone
injection about 2–3 minutes had passed. Respiration seemed
to be adequate, mucous membranes were pink and pulse re-
gular and strong. The horse was lifted to transport it into surge-
ry but within less than 30 seconds, it struggled so hard, that it
had to be lowered again. It needed another 1.5 gr of thiopen-
tone to prevent it from moving. As the anaesthetist judged the
horse to be uncontrollable it was transported back to the reco-
very box, where it lay calm on its side for 42 minutes. Then it
got up excellently. The data from this horse are excluded from
the other paragraphs.
Cardiopulmonary effects
Arrhythmias
Three horses showed II degree AV blocks just prior to anaesthe-
sia induction. One horse was treated with atropine before
anaesthesia induction (see above). In another horse heart rate
before anaesthesia induction had fallen from 48 to 28 beats/
min and was not treated, but atropine was administered 15
min after anaesthesia induction as heart rate had dropped to
15. The horse was 370 kg and the initial dose of atropine was
1 mg i.v. followed by another 2 mg i.v. after 5 minutes as heart
rate was still 15. Within another 2 minutes AV blocks disap-
peared, heart rate rose to 52 beats/min and remained there
until the end of the surgery 65 minutes after anaesthesia induc-
tion. In the third horse, that showed II degree AV blocks just
prior to anaesthesia induction these blocks disappeared spon-
taneously 40 minutes after anaesthesia induction.
Fig. 1: Mean heart rates (±  SD) in 15 clinical cases anaesthetised with
metetomidine-propofol, previously to any drug administration (pre), before
anaesthesia induction (bef) and every five minutes during anaesthesia;
time points at which heart rates of all animals (n=15) are available.
Mittlere Herzfrequenz (±  SD) von 15 klinischen Patienten vor der Appli-
kation jeglicher Medikamente (pre), vor der Anästhesieeinleitung (bef)
und alle 5 Minuten unter Medetomidin-Propofol Anästhesie; Zeitpunk-
te zu welchen Herzfrequenzen aller Tiere gemessen wurden
Fig. 2: Mean heart rates (±  SD) of 12 horses and ponies anaesthetised
in the field; time points at which heart rates of all animals (n=15) are
available.
Mittlere Herzfrequenz (±  SD) von 12 Pferden und Ponies, anästhesiert
unter Feldbedingungen, vor der Applikation jeglicher Medikamente
(pre), vor der Anästhesieeinleitung (bef) und alle 5 Minuten unter
Medetomidin-Propofol Anästhesie; Zeitpunkte zu welchen Herz-
frequenzen aller Tiere gemessen wurden
2 horses showed sinus arrhythmias during the anaesthesia. In
one horse, they started immediately after anaesthesia induc-
tion and ceased after 45 minutes; in the other horse they star-
ted 40 minutes after anaesthesia induction but remained throu-
ghout the whole anaesthesia.
Heart rate
Mean heart rates at time points at which data of all animals
were available (clinical cases during 50 mins, in the field du-
ring 20 mins) are shown in figure 1 and 2. In the clinical
cases heart rate was significantly reduced compared to pre-
sedation values (p<0.01 up to 25 mins and p<0.05 30–50
mins after anaesthesia induction). In the stallions, anaesthe-
tised in the field, heart rates were significantly reduced
(p<0.01) compared to presedation values throughout the
whole anaesthesia.
Arterial blood pressures
The application of an intra-arterial catheter proved to be diffi-
cult in some horses. In 5 horses the anaesthetist was not able to
sucessfully place an intra-arterial catheter.
Arterial blood pressures were very stable in individual animals
over time and did not show variations greater than ±  11
mmHg. Occurring variations coincided with presence or ab-
sence of surgical stimuli. Mean arterial blood pressure (MAP)
ranged from 95.6–111 with a range from 84–128.
In the one horse, in which heart rate 15 minutes after induc-
tion had dropped to 15 beats/min, for the first 20 minutes
pulse was hardly palpable and mucous membranes looked
very pale with no assessable capillary refill time (CRT). In this
horse, for the first 25 minutes no intraarterial catheter could
be placed and thus no pressure measurements were obtained.
After 30 minutes (i.e. after the atropine) mucous membranes
looked pink and CRT was 2 secs. MAP was 84 mmHg and
remained like this until the end of the anaesthesia. This horse
underwent emergency surgery, because it had suffered from
severe injuries on its legs including loss of an unknown amount
of blood. PCV before anaesthesia induction had been 24%
and plasma protein contents 68 g/L, otherwise clinical exami-
nation had revealed no other problems.
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Respiratory rate and arterial blood gases
Mean respiratory rates of clinical cases at time points at which
data of all animals were available (during 45 minutes) are
shown in figure 3. All animals showed a slowing of the respi-
ratory rate after sedation with medetomidine. After anaesthe-
sia induction four horses showed an increase of respiratory
rate to presedation values (±  2 breaths/min). In the first mi-
nute after becoming recumbent all horses showed pauses in
respiration of 20–60 secs, but phases of apnoea no longer
occurred.
During anaesthesia respiratory rate was stable in all animals.
Careful observation detected that some changes of tidal
volume or respiratory rate occurred with surgical stimulation
or changes in anaesthetic depth.
From anaesthesia induction onwards until the recovery phase,
4 animals, 3 of the horses in the field and one under clinical
conditions showed irregular breathing patterns with respirato-
ry breaks of up to 20 seconds, occurring every 1–3 minutes.
Time course of mean arterial blood gas values are given in
figure 4. and 5. Mean paO2 values ranged from to 23.2–31.8
kPa and mean paCO2 values ranged from 6.1 to 7.0 kPa.
Lowest and highest registered paO2 values were 11.7 and 59.7
kPa respectively. Lowest and highest registered paCO2 values
were 5.2 and 8.5 kPa respectively.
Other than cardiopulmonary effects
All animals appeared very lightly anaesthetised, showing brisk
palpebral reflexes and nystagmus of various degrees. Obser-
vers not involved in the experiments, were all amazed, that the
animals did not move.
During anaesthesia a total of six animals (2 in the field and 4
in clinics) showed movements in response to surgical stimuli.
Once this was only a shivering in the neck region, twice a
slight nodding with the head and 3 times a movement with the
foot. These movements were always slow in nature and easily
controlled by bolus injections of 0.05–0.1 mg/kg propofol. In
horses that had an intra-arterial catheter in place a rise in mean
arterial blood pressure of 10–15 mmHg preceeded these
movements.
Urination during or just after anaesthesia occurred in all ani-
mals. In clinical patients with estimated anaesthesia duration
of >60 minutes, from the fourth clinical case onwards, urina-
ry catheterisation was performed after anaesthesia induction.
Anaesthesia duration, propofol infusion rates and surgical
conditions
In the clinical cases mean anaesthesia time was 79.0 ±  36.04
(50–175) mins and in the field 30.0 ±  11.40 (20–50) mins.
During all surgeries, especially the castrations, surgeons were
satisfied with the good relaxation of the animals. The obvious
lack of violent „purposeful movements“ and the ease of con-
trollability is another noted advantage of this protocol.
Propofol infusion rates of the two groups are presented sepa-
rately; as under field conditions the horses weights were only
judged and they were also premedicated with acepromazine
and not infused with medetomidine. Mean propofol infusion
rates in the clinical patients are represented in figure 6. They
ranged from 0.085–0.105 mg/kg/min with an individual
range of 0.05–0.18 mg/kg/min. In all but three animals, the
individual infusion rate could be maintained within ± 0.015
mg/kg/min from the beginning of the anaesthesia onwards. In
two animals, that suffered from fever (foal with polyartheritis) or
had suffered from acute blood loss (injured horse, in which
blood pressure and heart rate problems occurred initially) the
initially chosen dose rate of 0.1 mg/kg/min was reduced im-
mediately to 0.06 mg/kg/min, as their cardiovascular function
Fig. 3: Mean respiratory rates (±  SD) in 15 clinical cases anaesthetised
with medetomidine-propofol, previously (pre) to any drug administration,
before (bef) anaesthesia induction and every five minutes during
anaesthesia. Time in mins after anaesthesia induction, n decreasing
with time.
Mittlere Atemfrequenzen (±  SD) von 15 Patienten vor der Applikation
jeglicher Medikamente (pre), vor der Anästhesieeinleitung (bef) und
alle 5 Minuten unter Medetomidin-Propofol Anästhesie; n mit der Zeit
abnehmend
Fig. 4 : Mean paCO2 in 11 horses anaesthetised under clinical
conditions using medetomidine-propofol.
Mittlere paCO2-Werte von 11 Pferden welche unter klinischen Bedin-
gungen mit Medetomidin-Propofol anästhesiert wurden.
Fig. 5 : Mean paO2 in 11 horses anaesthetised under clinical conditions
using medetomidine-propofol. Spontaneous ventilation, inspired O2
concentration >90%.
Mittlere paCO2-Werte von 11 Pferden welche unter klinischen Bedin-
gungen mit Medetomidin-Propofol anästhesiert wurden.Atmung spon-
tan inspiratorische O2- Konzentration > 90%
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and the reduction of reflexes suggested a too deep level of
anaesthesia. One pony that was anaesthetised for castration
and had been very difficult to handle before anaesthesia, had
to be bolused with propofol several times within the first 10
minutes reaching an average dose rate of 0.18 mg/kg/min of
propofol. In this pony dose rate could be reduced with time
reaching levels of 0.13 mg/kg/min 50 minutes after anaesthe-
sia induction.
In the horses and ponies anaesthetised under field conditions
mean propofol infusion rates reached from 0.063–0.18 mg/
kg/min, according to the judged weight.
Recovery
Data concerning recovery are presented in table 3. In the clini-
cal cases recovery scores were the following: 2x3, 2x4 and
10x5 and in the field: 2x3, 6x4 and 4x5. The clinical cases took
10x1, 2x2, 1x3 and 1x4 attempts to stand and the horses in the
field 10x1 and 2x2 attempts to stand.
Of the clinical cases, one pony was not allowed to recover as it
suffered from inoperable lesions and had to be euthanized 60
minutes after anaesthesia induction.
A 6 week old foal, that was suffering from polyarthritis and had
been anaesthetised 3 times (once with xylazine-ketamine fol-
lowed by isoflurane and twice with xylazine-ketamine-clima-
zolam, as described by Bettschart-Wolfensberger et al., 1996)
within 10 days before the medetomidine-propofol anaesthesia.
In this foal the recovery protocol was slightly changed. The state
of health had not changed since its admission to the clinic and
it had been pyrexic for 14 days. After the first three anaesthetics
(duration 55–60 minutes) the foal had taken 62, 47 and 45
minutes to stand up, even though recovery had been assisted.
Therefore it was not sedated for recovery after medetomidine
propofol. 15 minutes after the end of infusion, at which stage it
had not moved or shown any signs of recovery, it was given
atipamezole by very slow i.v. injection (60 µg/kg atipamezole
diluted with saline to a volume of 20 ml). After a dose of 3 mg
of atipamezole (=21 mg/kg atipamezole, that had taken about
2 minutes to inject) the foal started swallowing and moving its
limbs. It was standing alertly within another 1.2 minutes and
started sucking immediately.
The stallion that had shown poor anaesthesia induction quality
in the field showed muscle tremor of the whole body and espe-
cially the limbs for 3 minutes during recovery.
Discussion
The aim of the present study was to test the practical use of a
new TIVA regime for equidae (Bettschart-Wolfensberger et al.,
2001a+b). After a total of 27 anaesthesias the clinical testing
of this regime was terminated, because of a relatively high inci-
dence of unsatisfactory anaesthesia inductions, and one totally
unacceptable induction phase in a horse, that almost resulted
in injuries of people involved.
Medetomidine proved to be suitable as a preanaesthetic seda-
tive in a practical situation. The previously tested dose of 7 µg/
kg was increased, based on subjective decision by an expe-
rienced anaesthetist. This would be routine practice with other
alpha2-adrenoceptor agonists under similar circumstances. None
of the clinically anaesthetised horses needed further sedation
but all the stallions castrated under field conditions did. These
horses had not been handled at all, had been transported just
before the anaesthetic and in six of them the application of an
intravenous catheter had only been possible after the admini-
stration of some intramuscular acepromazine. Nevertheless the
further administration of 2–6 µg/kg medetomidine resulted in
good sedation with total lack of response to under clinical cir-
cumstances normal external stimuli, such as people talking or
approaching and other horses walking by. Because of this deep
level of sedation, achieved in all horses, the author is con-
vinced that none of the bad anaesthesia inductions or nonideal
recoveries in this study can be attributed to lack of sedation.
The incidence of nonideal or bad anaesthesia induction phases
in the present study, was relatively high compared to previous
propofol reports. Nolan (1989) reported one fair anaesthesia
induction phase out of four ponies that were sedated with deto-
midine and anaesthesia induced with propofol and Nolan and
Hall (1985) reported some paddling after anaesthesia induc-
tion when the horses had been sedated with acepromazine and
butorphanol but only smooth induction phases after sedation
with xylazine. Taylor (1989a), Aguiar et al. (1993) or Pablo et
al. (1997) all used detomidine or xylazine for premedication
and propofol as an induction agent and only reported good
anaesthesia inductions. None of the ponies or horses that
weighed < 250 kg showed any problems during anaesthesia
induction but the incidence of paddling after induction increased
with increasing weight of the horse. In the larger horses the
injection of the total dose of propofol took up to 55 secs. When
these trials were performed, propofol was only available as a
1% solution resulting in very high injection volumes. Since the
completion of this current work a 2% solution has become avai-
lable. The onset of unconsciousness and anaesthesia is depen-
dent on the time which the drug takes to achieve certain levels
at its effect site, for propofol the brain, which again is mainly
dependent on circulation to the brain and the drugs lipid solu-
bility (Thurmon et al., 1996). From previous studies we know
that a medetomidine bolus induces cardiovascular changes si-
milar to other α2-adrenoceptor agonists in equidae (Bettschart-
Wolfensberger et al., 1999). The reduced cardiac index with
medetomidine probably reduces the amount of propofol rea-
ching the brain within a certain time and thus delays onset of
unconsciousness. The number of horses in which propofol was
used as an induction agent is low (Nolan and Hall, 1985; No-
lan, 1989; Aguiar et al., 1993; Pablo et al., 1997) and thus
only a blind comparison of different sedatives followed by pro-
pofol inductions would be able to really test if anaesthesia in-
ductions are worse with medetomidine premedication than fol-
lowing other sedatives.
Fig. 6: Mean propofol infusion rates in mg/kg/min in 15 clinical
patients anaesthetised with medetomidine-propofol TIVA. Time in mins
after anaesthesia induction, n decreasing with time.
Mittlere Propofoldosierungen in mg/kg/min bei 15 klinischen Patien-
ten welche mit Medetomidin-Propofol anästhesiert wurden. Zeit in
Minuten nach Anästhesieeinleitung, n mit der Zeit abnehmend
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One of the stallions anaesthetised in the field showed not only
paddling of the limbs, but also spasms of the whole body im-
mediately after anaesthesia induction as well as during recove-
ry. In dogs different authors have reported spasms and stiffness
after the use of propofol combined with different sedatives (Hall
and Chambers, 1987; Watney and Pablo, 1992; Nolan et al.,
1993; Kramer et al., 1995), the causes of which remained
unknown. However Lagerweij et al. (1993) reported sponta-
neus limb movements during 2 hours of propofol infusion in
dogs that did never occur if the same dogs were premedicated
with medetomidine.
The horse that showed a very poor anaesthesia induction had
been anaesthetised already in the same clinic 7 months before
this episode. At that time anaesthesia had been induced with
xylazine (1.1 mg/kg)-ketamine (2mg/kg)-diazepam (0.02 mg/
kg) and maintained with halothane. On this first occasion also
a bolus of 0.5 gr thiopentone had been necessary to intubate
and transport the horse into theatre, but otherwise anaesthesia
had been uneventful. Why the use of medetomidine-propofol
resulted in an absolutely unacceptable, and even with thiopen-
tone, hardly controllable situation remains unknown. Horses
dying of hypoxaemia can react violently and show extensive
movement. We were not able to take an arterial blood sample
in this horse, as it struggled so hard. Nevertheless we are con-
vinced, that no severe hypoxaemia was present as mucous
membranes were always pink, pulse rate regular and strong,
the horse seemed to the anaesthetist to be conscious and the
paddling ceased when thiopentone was administered. The in-
fluence of atropine administered just prior to induction in this
horse is another unknown factor.
Already in previous medetomidine-propofol reports it was ob-
vious that judgement of depth of this anaesthesia differs from
that during inhalation anaesthesia. In the present study the au-
thor had already been familiar with the technique and did not
have problems to control depth of anaesthesia. Clinical judge-
ment of depth of anaesthesia is one of the major „holy grails“
in anaesthesia. As long as a horse doesn’t show purposeful
movements during anaesthesia, the anaesthetist can not be
certain, if depth of anaesthesia is adequate. The prompt reco-
veries noted in all animals suggest, that none of the horses
were overdosed. In all animals propofol infusion was started at
an infusion rate of 0.1 mg/kg/min. Only in a foal and one
horse, both in poor condition, was the dose rate reduced to
0.06 mg/kg/min rapidly after anaesthesia induction. If the pa-
tient did not show any reaction on surgical stimulus the infusion
rate was decreased by 0.01 mg/kg/min every 15–20 minutes.
Mean infusion rates of propofol of 0.85–0.105 mg/kg/min that
were necessary to maintain anaesthesia were within the ranges
determined in previous studies (Bettschart-Wolfensberger et al.,
2001a+b). These infusion rates were much lower than those
used by other authors that combined propofol with various se-
datives, analgesics or muscle relaxants (Nolan and Hall, 1985;
Taylor, 1989a; Matthews et al., 1994; Taylor et al., 1997; Mama
et al., 1998). Only combination of propofol with constant ket-
amine infusion resulted in propofol infusion rates comparable
with the one described here (Flaherty et al., 1997). In this cur-
rent study we maintained anaesthesia as light as possible, to
reduce cardiopulmonary side effects, thus making a fatal out-
come less likely. This resulted in purposeful movements in 6
horses. Contrary to TIVA based on ketamine (Wolfensberger,
1992), these movements were always gentle and easy to con-
troll by slow injection of a propofol bolus of 0.05–0.1 mg/kg.
Although anaesthesia was maintained at such a light level the
surgeons always considered muscle relaxation good and as
the occurring movements were always gentle everybody in thea-
tre gained quickly confidence to the new anaesthetic.
Hypoxaemia has been the biggest problem with medetomi-
dine-propofol TIVA in the previous studies (Bettschart-Wolfens-
berger et al., 2001a+b). Thus clinical patients were allowed to
breath >90% oxygen from the start of anaesthesia. Mean paO2
values, although lower than theoretically possible with pure
oxygen ventilation, were within ranges that are common in cli-
nically anaesthetised horses breathing spontaneously pure oxy-
gen. It has been recognised a long time ago, that in recumbent
horses often huge alveolar-arterial oxygen differences occur (Hall
et al., 1968), mainly attributable to ventilation-perfusion distur-
bances. The minimal paO2 value of 11.7 kPa registered in a
horse on its back 60 minutes after anaesthesia induction cannot
be interpreted as an unacceptable respiratory depression due
to medetomidine-propofol. In a clinical survey in horses that
were anaesthetised with halothane in oxygen and breathing
spontaneously, 5% of the horses on their back developed hypo-
xaemia (defined as paO2<60 mmHg=8 kPa) from the begin-
ning of anaesthesia and 35% by its end, 101 minutes after
anaesthesia induction (Day et al., 1995). We still do lack an
explanation for the relatively large number of severe hypoxae-
mias, that occurred in the previous studies with medetomidine-
propofol (Bettschart-Wolfensberger et al., 2001a+b). The pre-
sent results suggest, that medetomidine-propofol, administe-
red at adequate dose rates does not induce greater hypoxaemia
than do other general anaesthetics in horses.
PaCO2 values were within normal limits for horses under gene-
ral anaesthesia with a relatively low maximal value of 8.5 kPa
registered in a horse in lateral recumbency, 75 minutes after
anaesthesia induction.
Bradyarrhythmias after the use of medetomidine are common
in dogs (Vainio et al., 1986/87; Lombard et al., 1989; Nilsfors
et al., 1989; Kramer et al., 1996). Their effects, other than a
reduction in cardiac output and the potential danger during a
Tab. 3: Recovery times (in minutes from end of infusion) and scores in
14 equidae anaesthetised under clinical conditions (Clin) or in the
field (Field) following medetomidine-propofol infusion anaesthesia.
Aufwachzeiten (Zeit in Minuten nach Beendigung der Infusion) und
Qualität der Aufwachphase von 14 Equiden unter klinischen Bedin-
gungen (Clin) oder unter Feldbedingungen (Field)
(Clin, n=14)) (Field, n=12)
time of extubation (mins)
9.9 ± 6.92
(2.1–25.2)
_
1. movement (mins) 13.5 ± 7.39
(2.1–25.2)
12.6 ± 6.66
(6.1–24.6)
into sternal recumbency (mins) 18.2 ± 9.24
(3.2–36.0)
18 1 ± 10 03
(8.7–31.8)
duration of sternal recumbency
(mins)
8.5 ± 8.06
(0.52–26.2)
2.0 ± 1.66
(0–4.45)
standing (mins) 27.1 ± 9.96
(12.2–44.8)
20.2 ± 11.19
(10.0–35.1)
nr. of attempts to stand 1.5 ± 0.94
(1–4)
1.2 ± 0.39
(1–2)
recovery score (1–5; 1 = worst,
5 = best)
4.6 ± 0.76
(3–5)
4.2 ± 0.75
(3–5)
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general anaesthetic, are a matter of discussion. Anticholiner-
gics can prevent these bradyarrhythmias, but their use has been
questioned, as it may result in very high blood pressures
(Bergström, 1988; Alibhai et al., 1996). In horses a reduction
of heart rate after the use of any α2-adrenoceptor agonist is
common (England and Clarke, 1996). Pretreatment with anti-
cholinergics is not recommended as anticholinergics also in-
duce disturbances of vision and depression of gastrointestinal
motility (Hall and Clarke, 1983). Nevertheless in two horses in
which heart rates had dropped to 15 beats/min atropine was
administered to maintain cardiac output. Compared to atro-
pine doses of 0.005–0.01 mg/kg used by other authors (Short
et al., 1986; Gasthuys et al., 1990) the doses of 0.003 and
0.008 mg/kg we used were rather low but resulted in heart
rates within normal ranges within 5 minutes.
In dogs heart rate tends to rise during propofol infusion follo-
wing medetomidine premedication (Lagerweij et al., 1993;
Hammond and England, 1994; Hall et al., 1997). A rise in
heart rate occurred in the clinical cases in this study but not in
the horses in the field, probably because the observation
period had been too short.
Two horses showed sinus arrhythmias during the propofol infu-
sion, a fact that had not been observed during the anaesthe-
sias of the ponies in the previous medetomidine-propofol stu-
dies (Bettschart-Wolfensberger et al., 2001a+b), significance
of which is unknown.
After anaesthesia induction the placement of an arterial ca-
theter was not always easy probably due to peripheral vaso-
constriction induced by medetomidine (Docherty and Mc-Grath,
1980). Such problems, but with the catheterisation of veins
have been reported in cats after the premedication with mede-
tomidine (Becker and Oechtering, 1996). Peripheral vasocon-
striction was also noted by other authors. Lagerweij et al. (1993)
reported frequently cadaveric appearence of the oral mucous
membranes and paleness of the conjunctival membranes after
medetomidine premedication and explained this with hypo-
perfusion of some vascular beds due to increased vascular
resistance from selective vasoconstriction. We noted alarmin-
gly pale mucous membranes in one horse only, the one in
which heart rate fell to 15 beats/min. Circulation was failing
probably due to the reduction of heart rate caused by medeto-
midine but also due to a fall in blood pressure caused by pro-
pofol. In this horse the amount of blood loss and the general
status before the anaesthesia had probably been underesti-
mated. In the horses in which arterial blood pressure was mea-
sured, it was very stable and within ranges commonly accep-
ted as being adequate during horse general anaesthesia. The
clinical significance of an adequate blood pressure should not
be overinterpreted during medetomidine-propofol anaesthe-
sia. Data from previous studies in ponies (Bettschart-Wolfens-
berger et al., 2001a+b) and from dog studies suggest that
arterial blood pressure is mainly dependent on the proportion
of propofol plasma concentration to medetomidine plasma
concentration (Vainio, 1991; Lagerweij et al., 1993; Hall et
al., 1997). Thus a horse can show a „good“ blood pressure
even with a low cardiac output, if peripheral vasoconstriction
is present.
Urine production was not assessed objectively in the present
study. Nevertheless horses were noted to urinate unusually
large quantities either during anaesthesia or recovery, or im-
mediately after recovery. The problem of very large urine pro-
duction due to the use of medetomidine had been noted pre-
viously (Bettschart-Wolfensberger et al., 2001 a+b). Neverthe-
less it was surprising that stallions undergoing castrations of
only 20 minutes duration urinated during anaesthesia or right
after recovery. Urinating during anaesthesia can contaminate
the surgical site and an extended bladder may cause discom-
fort during recovery. The increased fluid loss during longer sur-
geries should be taken into account and replaced with i.v. fluid.
In clinical patients we started, after the fourth case, to regularly
induce an urinary catheter at the beginning of surgery to re-
duce problems. However this enormous urine production is cer-
tainly a relatively big disadvantage of the present TIVA regime.
In the present study the protocol was such that none of the
clinical patients received preemptive analgesia. To administer
an analgesic before surgery is considered the best option to
prevent „wind up“ phenomenon (Woolf, 1983). Medetomidine
itself has marked analgesic properties and we wished to get an
idea if the analgesia persists any longer than the sedative
action. Thus we chose not to pretreat the horses with analge-
sics. We did not perform any sophisticated testing of analgesia
or present pain after surgery, but only watched the horses right
after recovery in their box as well as one and 4 hours later. All
the horses started eating as soon as they were returned to their
box and remained totally calm as long as they were observed.
We were amazed by this fact as, at least in the four intraabdo-
minal surgeries we were expecting some reactions. In such sur-
geries the routine preoperative application of flunixin meglu-
mine is very often insufficient, many horses show some signs of
colic after surgery and have to be treated with supplemental
analgesia. This postoperative analgesic action of medetomi-
dine could be a big advantage of the use of this drug in the
perioperative period.
In previous studies (Bettschart-Wolfensberger et al., 2001a+b)
the use of atipamezole after medetomidine propofol anaesthe-
sia has been tested. It was concluded, that atipamezole should
not be routinely used as recovery was not improved and, as its
use could result in antagonism of not only the sedative but also
the analgesic component of medetomidine. In foals it is very
important, that they wake up as soon as possible from general
anaesthesia to start sucking. During recovery an infusion thera-
py is not possible and the foals can become hypoglycaemic
and their energy metabolism can disregulate. This can be very
harmful especially in foals that suffer from other diseases.
Matthews et al. (1994) have reported the successful use of pro-
pofol in foals with very quick recoveries. Thus we decided to
use medetomidine-propofol followed by atipamezole in reco-
very in a foal that underwent its fourth anaesthetic and was
severly ill. As antibiotics, low plasma proteins, poor state of
health and neonatal age certainly influence pharmacokinetics
of a drug, we had no idea of the necessary dose rate of atipa-
mezole. We have shown that the onset of its action is very quick
(Bettschart-Wolfensberger et al., 1999). Thus we gave it by very
slow injection and stopped as soon as we noted signs of awa-
kening. It was impressive how within not even two minutes the
foal was standing, totally alert and sucking.
In horses recovery quality is one of the most important features of
an anaesthetic regime, as fatalities often happen during this pe-
riod (Young and Taylor, 1993). In experimental animals,
testing of recovery quality is very difficult, as it usually improves
with repeated anaesthetics. The horses are not in an unfamiliar
environment any more and most often no pain is present. Mul-
tiple observations on experimental animals will give results diffe-
rent from those of single observations on a large number of ani-
mals. As reported by other authors that used propofol in horses,
overall recovery quality was good and of acceptable length. We
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failed to test if fatalities during recovery could be reduced by
the routine use of medetomidine-propofol TIVA, as a much
larger number of clinical cases would be necessary to do so.
In the present study we have shown that an infusion of medeto-
midine-propofol results in good quality and easy controllable
anaesthesia. Cardiovascular changes were within expected ran-
ges and hypoxaemia was no more severe than during routine
general horse anaesthesia. However problems with anaesthe-
sia induction limited the use of propofol and implicated the
termination of the trial. Further investigations of alternative in-
duction agents are necessary. The availability of a medetomi-
dine antagonist proved to be very useful to speed recovery in
one foal which was severely ill.
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